American Society of Clinical Oncology (ASCO)
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place inChicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate DB-1310 and B7H3 ADC candidate DB-1311/BNT324, which is being...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
VINEXPO ASIA 2025 OFFERS CLARITY FOR ASEAN TRADE IN SHIFTING LANDSCAPE
SINGAPORE, June 3, 2025 /PRNewswire/ -- In a shifting global landscape, clarity matters. From 27 to 29 May, Vinexpo Asia 2025 gathered8,998 trade participants at Marina Bay Sands, reinforcing its position as both a business catalyst and a strategic forum for market orientation and collective fore...
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
* Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts of elacestrant plus targeted therapy combination arms, will be presented. * These data highlight elacestrant's potential ro...
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting
CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), today announced that its collaborator, Pfizer, will present an abstract detailing the first-in-human Phase 1 clinical study design of MesoC...
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting
Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM TOKYO, May 22, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI...
VINEXPO ACADEMY LEADS THE CONVERSATION AT VINEXPO ASIA 2025
SINGAPORE, May 21, 2025 /PRNewswire/ -- Inresponse to the rapid transformation in the global wine and spirits trade, Vinexpo Asia 2025 returns to Singapore with an expanded and strategically curated Vinexpo Academy programme. Held at Marina Bay Sands from 27–29 May, the event will feature more th...
Questex's IHIF Asia Unveils 2025 Conference Programme, Unites Hospitality Community in the Asia-Pacific Region to Connect Capital with Investment Opportunities
Registration Open for September 2025 Event
HONG KONG, May 19, 2025 /PRNewswire/ -- Questex's International Hospitality
Investment Forum (IHIF) Asia
Blending Innovation with Tradition: Thailand Brings Holistic Wellness to Expo 2025
BANGKOK, May 16, 2025 /PRNewswire/ -- Within just the first month of Expo 2025
in Osaka, Japan, the Thai Pavilion has welcomed over 200,000 visitors charmed
by Thailand's fusion of cutting-edge innovation and rich cultural heritage.
Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences
* The latest 2-year follow-up data on golidocitinib as a maintenance therapy for peripheral T-cell lymphoma (PTCL) patients who achieved tumor response after first-line systemic therapy will be presented orally at the 2025 ICML * A pooled safety and efficacy analysis of two Phase I/II studies ...
Beijing Week of China Pavilion at Expo 2025 Osaka Kansai Japan Kicks off
OSAKA, Japan, May 9, 2025 /PRNewswire/ -- On May 8, Beijing Week of China Pavilion at Expo 2025 Osaka Kansai Japan (Beijing Week) officially kicked off under the theme "Beautiful Beijing Shining at the Expo." The event attracted over 100 attendees, including government officials, representatives ...
The MarTech Summit Jakarta, 25 June 2025 at The St. Regis Jakarta
JAKARTA, Indonesia, May 2, 2025 /PRNewswire/ -- Halo Jakarta! The MarTech Summit is returning to Jakarta for the third time, and this year's theme is 'Driving MarTech From Local Insights To Global Impact.' Join us In-Person at The St. Regis Jakarta on 25 June 2025, the MarTech Summit will bring t...
Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025
* DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after covalent or non-covalent BTK inhibitors and BTK degraders was selected for oral presentation ...
Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting
CHENGDU, China, April 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held inChicago from May 30 to June 3. Resu...
HIKSEMI Unveils GEN5 SSD and Immersive Storage Solutions at the 137th Canton Fair
GUANGZHOU, China, April 17, 2025 /PRNewswire/ -- HIKSEMI made a striking debut at the 137th Canton Fair, held fromApril 15th to 19th. Under the theme "Innovations Beyond Storage", HIKSEMI showcased how cutting-edge technologies like PCIe 5.0 are breaking through traditional storage limitations to...
Grand Opening of the April 2025 Global Sources Hong Kong Shows Phase I: Esports Trend, IP Collaborations, and Blind Box Economy Reshape Future of Electronics Trade
HONG KONG, April 11, 2025 /PRNewswire/ -- The April 2025 Global Sources Hong Kong Shows officially opened today. The first of three phases runs fromApril 11 to 14 at AsiaWorld-Expo, comprising major international trade shows for gaming, consumer electronics and electronic components. The exhibiti...
Regional Trade, Premium FIT & Business Opportunities Aplenty in ITE Hong Kong
HONG KONG, March 31, 2025 /PRNewswire/ -- Asia's leading international travel fair and named MEGA EVENT by government, ITE Hong Kong 2025 comprises 39th ITE (Leisure) and 20th ITE MICE, will be held from June 12 to 15 in HKCEC with two days each for trade and public. Pre-pandemic ranked Asia's 3...
Week's Top Stories
Most Reposted
SGTraDex and IMDA Receive Pro-Enterprise Impact & Partnership Award for Interoperable Digital Documents Against Payment Trade Cooperation
[Picked up by 313 media titles]
2025-11-25 15:37
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 311 media titles]
2025-11-27 07:25Zenika Singapore Announces Two Key Leadership Appointments to Accelerate Regional Growth and AI Engineering Mastery
[Picked up by 291 media titles]
2025-11-24 10:00
SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 290 media titles]
2025-11-29 09:00
HOTEL GROOVE SHINJUKU strengthens its services for deaf and hard of hearing guests
[Picked up by 288 media titles]
2025-11-25 10:00
Most Read
LightInTheBox to Hold 2025 Annual General Meeting on December 19, 2025
STAGWELL (STGW) REVEALS NEW SINGAPORE HUB TO POWER AI-DRIVEN GROWTH AND INNOVATION ACROSS APAC
